Detalhe da pesquisa
1.
Budget impact analysis of a machine learning algorithm to predict high risk of atrial fibrillation among primary care patients.
Europace
; 24(8): 1240-1247, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226101
2.
DrpB (YedR) Is a Nonessential Cell Division Protein in Escherichia coli.
J Bacteriol
; 202(23)2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32900831
3.
Anticoagulant selection for patients with VTE-Evidence from a systematic literature review of network meta-analyses.
Pharmacol Res
; 143: 166-177, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30905806
4.
Evaluating the effect of inequalities in oral anti-coagulant prescribing on outcomes in people with atrial fibrillation.
Eur Heart J Open
; 4(2): oeae016, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572087
5.
SAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S4-BOW-AF).
Eur Heart J Open
; 3(3): oead037, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37143610
6.
Can we collect health-related quality of life information from anticoagulated atrial fibrillation participants who have recently experienced a bleed? An observational feasibility study in primary and secondary care in Wales and through a UK online forum.
BMJ Open
; 13(10): e075335, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802619
7.
Sex Differences in Oral Anticoagulation Therapy in Patients Hospitalized With Atrial Fibrillation: A Nationwide Cohort Study.
J Am Heart Assoc
; 12(5): e027211, 2023 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36864741
8.
Investigating the feasibility of recruitment to an observational, quality-of-life study of patients diagnosed with atrial fibrillation (AF) who have experienced a bleed while anticoagulated: EQUAL-AF feasibility study protocol.
Pilot Feasibility Stud
; 8(1): 180, 2022 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962446
9.
Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England.
J Med Econ
; 25(1): 974-983, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834373
10.
An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range Descriptors Study (SWORDS).
Eur Heart J Cardiovasc Pharmacother
; 7(1): 40-49, 2021 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31774502
11.
Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm.
J Med Econ
; 23(4): 386-393, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31855091
12.
Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trial.
Contemp Clin Trials
; 99: 106191, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33091585
13.
Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study.
TH Open
; 3(4): e316-e324, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31592518
14.
Predicting atrial fibrillation in primary care using machine learning.
PLoS One
; 14(11): e0224582, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31675367
15.
Response: Letter to the editor.
Eur Heart J Cardiovasc Pharmacother
; 7(3): e27-e28, 2021 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33734310
16.
A cost-utility study of the use of pregabalin added to usual care in refractory neuropathic pain patients in a Swedish setting.
J Med Econ
; 15(6): 1097-109, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22712872
17.
A cost-utility study of the use of pregabalin in treatment-refractory neuropathic pain.
J Med Econ
; 15(2): 207-18, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22017236